A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome. [electronic resource]
- BMJ case reports Feb 2019
Publication Type: Case Reports; Journal Article
1757-790X
10.1136/bcr-2018-227785 doi
Adenocarcinoma--drug therapy Adrenal Cortex Hormones--therapeutic use Aged, 80 and over Antineoplastic Agents, Immunological--adverse effects Antineoplastic Combined Chemotherapy Protocols--therapeutic use Camptothecin--analogs & derivatives Colorectal Neoplasms--drug therapy Early Diagnosis Early Medical Intervention Fluorouracil--therapeutic use Humans Leucovorin--therapeutic use Liver Neoplasms--drug therapy Lung Diseases, Interstitial--chemically induced Male Panitumumab--adverse effects Radiography, Thoracic Tomography, X-Ray Computed